ey0018.8-8 | Clinical Trials – New Treatments | ESPEYB18
K Clement , E van den Akker , J Argente , A Bahm , WK Chung , H Connors , K De Waele , IS Farooqi , J Gonneau-Lejeune , G Gordon , K Kohlsdorf , C Poitou , L Puder , J Swain , M Stewart , G Yuan , M Wabitsch , P; Setmelanotide POMC and LEPR Phase 3 Trial Investigators Kuhnen
ey0018.8-9 | Clinical Trials – New Treatments | ESPEYB18
R Pivonello , M Fleseriu , J Newell-Price , X Bertagna , J Findling , A Shimatsu , F Gu , R Auchus , R Leelawattana , EJ Lee , JH Kim , A Lacroix , A Laplanche , P O'Connell , L Tauchmanova , AM Pedroncelli , BMK Biller
ey0018.8-10 | New Genes | ESPEYB18
D Eriksson , EC Royrvik , M Aranda-Guillen , AH Berger , N Landegren , H Artaza , AE Hallgren , MA Grytaas , S Strom , E Bratland , IR Botusan , BE Oftedal , L Breivik , M Vaudel , O Helgeland , A Falorni , AP Jorgensen , AL Hulting , J Svartberg , O Ekwall , KJ Fougner , J Wahlberg , BG Nedrebo , P Dahlqvist , PM Knappskog , ASB Wolff , S Bensing , S Johansson , O Kampe , ES Husebye
ey0018.8-11 | New Hope | ESPEYB18
SR Bornstein , M Malyukov , C Heller , CG Ziegler , G Ruiz-Babot , A Schedl , B Ludwig , C Steenblock
ey0018.8-12 | New Concerns | ESPEYB18
A Van't Westeinde , L Karlsson , A Nordenstrom , N Padilla , S Lajic
ey0018.8-13 | New Concerns | ESPEYB18
L Wallensteen , L Karlsson , V Messina , A Nordenstrom , S Lajic
ey0018.8-14 | New Paradigms | ESPEYB18
G Di Dalmazi , L Morandi , B Rubin , C Pilon , S Asioli , V Vicennati , A De Leo , F Ambrosi , D Santini , U Pagotto , V Maffeis , A Fassina , F Fallo
ey0018.8-15 | New Paradigms | ESPEYB18
ey0018.8-16 | Reviews | ESPEYB18
ey0018.8-17 | Reviews | ESPEYB18
MC Zennaro , S Boulkroun , FL Fernandes-Rosa